Literature DB >> 10997598

Adipose tissue as an endocrine organ.

G Ailhaud1.   

Abstract

The objective is to present a brief overview of peptide and non-peptide factors secreted from adipocytes and to describe some studies on the postulated role of the locally active triad angiotensinogen/angiotensinII/ prostacyclin in the development/enlargement of adipose tissue mass and increased blood pressure. In addition to the role of adipose tissue as an endocrine organ, the results emphasize the autocrine/paracrine mechanisms which are postulated to play a role in adipose tissue development and enlargement.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10997598     DOI： 10.1038/sj.ijo.0801267

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  11 in total

Review 1.  What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.

Authors:  Camille Vatier; Guillaume Bidault; Nolwenn Briand; Anne-Claire Guénantin; Laurence Teyssières; Olivier Lascols; Jacqueline Capeau; Corinne Vigouroux
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

2.  Human adipose angiotensinogen gene expression and secretion are stimulated by cyclic AMP via increased DNA cyclic AMP responsive element binding activity.

Authors:  Valérie Serazin; Esther Dos Santos; Mireille Morot; Yves Giudicelli
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

3.  Expression of ectolipid phosphate phosphohydrolases in 3T3F442A preadipocytes and adipocytes. Involvement in the control of lysophosphatidic acid production.

Authors:  Marie Francoise Simon; Astrid Rey; Isabelle Castan-Laurel; Sandra Grés; David Sibrac; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

4.  Suksdorfin Promotes Adipocyte Differentiation and Improves Abnormalities in Glucose Metabolism via PPARγ Activation.

Authors:  Mari Iwase; Takayuki Yamamoto; Kanako Nishimura; Haruya Takahashi; Shinsuke Mohri; Yongjia Li; Huei-Fen Jheng; Wataru Nomura; Nobuyuki Takahashi; Chu-Sook Kim; Rina Yu; Masahiko Taniguchi; Kimiye Baba; Shigeru Murakami; Teruo Kawada; Tsuyoshi Goto
Journal:  Lipids       Date:  2017-06-10       Impact factor: 1.880

5.  Obesity and cancer immunotherapy toxicity.

Authors:  Annie Mirsoian; William J Murphy
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

6.  Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise.

Authors:  Dorthe Lyngsø; Lene Simonsen; Jens Bülow
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

7.  Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects.

Authors:  E Faloia; C Gatti; M A Camilloni; B Mariniello; C Sardu; G G M Garrapa; F Mantero; G Giacchetti
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

8.  Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice.

Authors:  Annie Mirsoian; Myriam N Bouchlaka; Gail D Sckisel; Mingyi Chen; Chien-Chun Steven Pai; Emanuel Maverakis; Richard G Spencer; Kenneth W Fishbein; Sana Siddiqui; Arta M Monjazeb; Bronwen Martin; Stuart Maudsley; Charles Hesdorffer; Luigi Ferrucci; Dan L Longo; Bruce R Blazar; Robert H Wiltrout; Dennis D Taub; William J Murphy
Journal:  J Exp Med       Date:  2014-11-03       Impact factor: 14.307

9.  PPARs and Adipose Cell Plasticity.

Authors:  Louis Casteilla; Béatrice Cousin; Mamen Carmona
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

10.  Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity.

Authors:  Corneliu Henegar; Joan Tordjman; Vincent Achard; Danièle Lacasa; Isabelle Cremer; Michèle Guerre-Millo; Christine Poitou; Arnaud Basdevant; Vladimir Stich; Nathalie Viguerie; Dominique Langin; Pierre Bedossa; Jean-Daniel Zucker; Karine Clement
Journal:  Genome Biol       Date:  2008-01-21       Impact factor: 13.583
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.